Psychiatric Drug Discovery & Development, Princeton, NJ, USA

This meeting features the latest mechanistic approaches to the discovery and development of psychotherapeutic/psychopharmacologic agents, and highlights genomics, neurogenesis, and psychopathologic target-based discovery. Key areas of focus include schizophrenia, bi-polar disorder, depression, and anxiety disorders.